[CITATION][C] NASH limits anti-tumour surveillance in immunotherapy-treated HCC., 2021, 592

D Pfister, NG Núñez, R Pinyol, O Govaere, M Pinter… - … org/10.1038/s41586-021-03362-0
Save Cite Cited by 1 Related articles